Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SUV39H1 inhibitors(suppressor of variegation 3-9 homolog 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | US | 14 Sep 2024 | |
Melanoma | Preclinical | US | 14 Sep 2024 | |
Pancreatic Cancer | Preclinical | US | 14 Sep 2024 |